ARCHIVES

Early HER2 Positive Patients At Higher Risk of Recurrence

This article is from The Cancer Letter archive.

Vol. 32 No. 1 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

Letter: Legal Fund Seeks Support For Fisher

March 3, 1995

In Brief: MDA Treats Only 9% Of Texas Cancer Patients; Clinical Director Search Narrows To Three

March 12, 1976

LAK –IL-2 Studies Continue, Moertel Editorial Blasted

March 13, 1987

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

January 31, 2003

Secret Budget Sessions Ended; HEW Out To Lim. Future NCI Funds

April 2, 1976

Volasertib and LDAC Doubled Response in Older Patients

July 25, 2014